EMD (Enamel Matrix Derivative)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for EMD (Enamel Matrix Derivative), covering 2017-03-20 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Rh-PDGF vs EMD for Treatment of Intra-bony Defects [Phase 1, Phase 2]